The Peripheral Cannabinoid Receptor Type 1 (CB1) as a Molecular Target for Modulating Body Weight in Man

Abstract The cannabinoid 1 (CB1) receptor regulates appetite and body weight; however, unwanted central side effects of both agonists (in wasting disorders) or antagonists (in

March 29, 2024

The pattern of neurodegeneration in Huntington’s disease: a comparative study of cannabinoid, dopamine, adenosine and GABAa receptor alterations in the human basal ganglia in Huntington’s disease

In order to investigate the sequence and pattern of neurodegeneration in Huntington’s disease, the distribution and density of cannabinoid CB1, dopamine D1 and D2, adenosine

September 19, 2019

The Pathophysiology and the Therapeutic Potential of Cannabinoids in Prostate Cancer

Abstract Prostate cancer is the second most frequently occurring cancer diagnosed among males. Recent preclinical evidence implicates cannabinoids as powerful regulators of cell growth and

March 29, 2024

The other side of the leaf: Seizures associated with synthetic cannabinoid use

Please use this link to access this publication. Abstract There has recently been a marked rise in the medicinal use of cannabis for epilepsy and

September 5, 2025

The orphan receptor GPR55 is a novel cannabinoid receptor

Background: The endocannabinoid system functions through two well characterized receptor systems, the CB1 and CB2 receptors. Work by a number of groups in recent years

September 19, 2019

The nosology of addiction as a medical condition: a concise history and review of contemporary perspectives

Please use this link to access this publication. Abstract There is active scientific debate about the nature of addiction as a mental disorder, but with

April 11, 2026

The nonpsychoactive cannabis constituent cannabidiolis an oral anti-arthritic therapeutic in murinecollagen-induced arthritis

Abstract The therapeutic potential of cannabidiol (CBD), the major nonpsychoactive component of cannabis, was explored in murine collagen-induced arthritis (CIA). CIA was elicited by immunizing

January 11, 2024

The Nonpsychoactive Cannabis Constituent Cannabidiol Is a Wake-Inducing Agent

Cannabidiol (CBD) is a constituent of Cannabis sativa that induces nonpsychotropic effects, and some of its biological actions in sleep have been described by the

September 19, 2019

The Nonpsychoactive Cannabinoid Cannabidiol Inhibits 5-Hydroxytryptamine3A Receptor-Mediated Currents in Xenopus laevis Oocytes

The effect of the plant-derived nonpsychotropic cannabinoid, cannabidiol (CBD), on the function of hydroxytryptamine (5-HT)3A receptors expressed in Xenopus laevis oocytes was investigated using two-electrode

The New Runner’s High? Examining Relationships Between Cannabis Use and Exercise Behavior in States With Legalized Cannabis

Scientific literature examining cannabis use in the context of health behaviors, such as exercise engagement, is extremely sparse and has yielded inconsistent findings. This issue

August 15, 2023